Psilocybin: Largest study demonstrates efficacy against treatment-resistant depression
COMPASS Pathways plc, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that its groundbreaking Phase IIb clinical trial of the therapy COMP360 to psilocybin...